Sparc Microenvironment Signature (Sms) Analysis Of A Phase Ii Trial Of Neoadjuvant Gemcitabine (G), Epirubicin (E), And Nab-Paclitaxel (Nab-P) In Locally Advanced Breast Cancer (Labc)
JOURNAL OF CLINICAL ONCOLOGY(2010)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要